Darell Bigner
Clinical trials sponsored by Darell Bigner, explained in plain language.
-
Experimental brain tumor cocktail targets recurrent glioma
Disease control Recruiting nowThis early-phase trial tests a combination of two drugs—D2C7-IT and 2141-V11—for adults with recurrent malignant glioma, a serious brain cancer. The drugs are delivered directly into the tumor and nearby lymph areas. The main goal is to check safety and find the right dose in 90 …
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Brain cancer breakthrough? new immunotherapy combo targets recurrent glioblastoma
Disease control Recruiting nowThis early-stage trial is testing a combination of two immunotherapy drugs, D2C7-IT and 2141-V11, for people with recurrent glioblastoma, a fast-growing brain cancer. The treatment is delivered directly into the brain after surgery, followed by injections near the neck to boost t…
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental brain cancer cocktail shows promise in early trial
Disease control Recruiting nowThis study tests two experimental immunotherapy drugs, D2C7-IT and 2141-V11, in adults with a newly diagnosed, aggressive type of brain cancer called glioblastoma. The drugs are given directly into the brain after surgery, followed by injections near the neck lymph nodes. The goa…
Phase: PHASE1, PHASE2 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC